Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Message of humility
A religious fraternity in Rio considers the election of Pope Francis, a confirmation of their beliefs in poverty and simplicity. Slideshow
Sponsored Links
Bayer to partner on reversing bleeding from Xarelto
FRANKFURT |
FRANKFURT (Reuters) - German drugmaker Bayer said on Tuesday it planned to collaborate with U.S. peer Portola Pharmaceuticals to study several drugs that reverse the effects of its blood-thinner Xarelto.
Bayer said it expected to complete the study in the second half of this year.
Dangerous bleeding is one of the main risks of bloodthinners such as Xarelto, which are used against thrombosis or heart attacks, and drugs can be applied more widely if they have so-called "antidotes".
U.S. regulators last June rejected the use of Xarelto to prevent heart attacks and strokes in patients with acute coronary syndrome (ACS), citing the risk of bleeding.
Bayer said in September its development partner Johnson & Johnson had filed a response to the regulators' concerns.
(Reporting By Peter Dinkloh; Editing by David Cowell)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters